Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Importance Cardiogenic shock affects between 40 000 and 50 000 people in the US per
year and is the leading cause of in-hospital mortality following acute myocardial infarction …

Cardiogenic shock is a hemodynamically complex syndrome characterized by a low cardiac
output that often culminates in multiorgan system failure and death. Despite recent …

Importance Mechanical complications of acute myocardial infarction include left ventricular
free-wall rupture, ventricular septal rupture, papillary muscle rupture, pseudoaneurysm, and …

Background Single-center studies suggest that implementation of multidisciplinary
cardiogenic shock (CS) teams is associated with improved CS survival. Objectives The aim …

Cardiogenic shock (CS) remains the most common cause of mortality in patients with acute
myocardial infarction. The SHOCK trial (Should We Emergently Revascularize Occluded …

Background There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital
mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to …

Abstract Background The Society of Cardiovascular Angiography and Interventions (SCAI)
have recently proposed a new classification of cardiogenic shock (CS) dividing patients into …

Aim The management of cardiogenic shock remains a clinical challenge even in well‐
developed healthcare systems, best illustrated by its high mortality despite numerous …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …